标题
Targeting leucine-rich repeat kinase 2 in Parkinson's disease
作者
关键词
-
出版物
EXPERT OPINION ON THERAPEUTIC TARGETS
Volume 17, Issue 12, Pages 1471-1482
出版商
Informa Healthcare
发表日期
2013-11-09
DOI
10.1517/14728222.2013.842978
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Autophagy and microtubules - new story, old players
- (2013) R. Mackeh et al. JOURNAL OF CELL SCIENCE
- Interplay of LRRK2 with chaperone-mediated autophagy
- (2013) Samantha J Orenstein et al. NATURE NEUROSCIENCE
- Cerebrospinal fluid biomarkers in Parkinson disease
- (2013) Lucilla Parnetti et al. Nature Reviews Neurology
- Leucine-rich repeat kinase 2 functionally interacts with microtubules and kinase-dependently modulates cell migration
- (2013) Mareike Caesar et al. NEUROBIOLOGY OF DISEASE
- Biomarkers in Parkinson’s disease (recent update)
- (2013) Sushil Sharma et al. NEUROCHEMISTRY INTERNATIONAL
- Olfaction and imaging biomarkers in premotor LRRK2 G2019S-associated Parkinson disease
- (2013) M. Sierra et al. NEUROLOGY
- RAB7L1 Interacts with LRRK2 to Modify Intraneuronal Protein Sorting and Parkinson’s Disease Risk
- (2013) David A. MacLeod et al. NEURON
- Leucine-Rich Repeat Kinase 2 (LRRK2)-Deficient Rats Exhibit Renal Tubule Injury and Perturbations in Metabolic and Immunological Homeostasis
- (2013) Daniel Ness et al. PLoS One
- Mutant LRRK2 Elicits Calcium Imbalance and Depletion of Dendritic Mitochondria in Neurons
- (2012) Salvatore J. Cherra et al. AMERICAN JOURNAL OF PATHOLOGY
- Pharmacological inhibition of LRRK2 cellular phosphorylation sites provides insight into LRRK2 biology
- (2012) Jing Zhao et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- A link between LRRK2, autophagy and NAADP-mediated endolysosomal calcium signalling
- (2012) Patricia Gómez-Suaga et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Is inhibition of kinase activity the only therapeutic strategy for LRRK2-associated Parkinson's disease?
- (2012) Iakov N Rudenko et al. BMC Medicine
- Cerebral pathological and compensatory mechanisms in the premotor phase of leucine-rich repeat kinase 2 parkinsonism
- (2012) B. F. L. van Nuenen et al. BRAIN
- The LRRK2 G2019S mutant exacerbates basal autophagy through activation of the MEK/ERK pathway
- (2012) José M. Bravo-San Pedro et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Quantitative functions of Argonaute proteins in mammalian development
- (2012) D. Wang et al. GENES & DEVELOPMENT
- Phosphorylation of α-Synuclein Protein at Ser-129 Reduces Neuronal Dysfunction by Lowering Its Membrane Binding Property inCaenorhabditis elegans
- (2012) Tomoki Kuwahara et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Discovery of Selective LRRK2 Inhibitors Guided by Computational Analysis and Molecular Modeling
- (2012) Huifen Chen et al. JOURNAL OF MEDICINAL CHEMISTRY
- LRRK2 interactions with α-synuclein in Parkinson’s disease brains and in cell models
- (2012) Patrícia Silva Guerreiro et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Disrupted Autophagy Leads to Dopaminergic Axon and Dendrite Degeneration and Promotes Presynaptic Accumulation of -Synuclein and LRRK2 in the Brain
- (2012) L. G. Friedman et al. JOURNAL OF NEUROSCIENCE
- The neuropathology of genetic Parkinson's disease
- (2012) Markos Poulopoulos et al. MOVEMENT DISORDERS
- Progressive degeneration of human neural stem cells caused by pathogenic LRRK2
- (2012) Guang-Hui Liu et al. NATURE
- LRRK2 Controls an EndoA Phosphorylation Cycle in Synaptic Endocytosis
- (2012) Samer Matta et al. NEURON
- LRRK2 I2020T mutation is associated with tau pathology
- (2012) Sachiko Ujiie et al. PARKINSONISM & RELATED DISORDERS
- LRRK2 Phosphorylates Tubulin-Associated Tau but Not the Free Molecule: LRRK2-Mediated Regulation of the Tau-Tubulin Association and Neurite Outgrowth
- (2012) Fumitaka Kawakami et al. PLoS One
- Microtubule Destabilization Is Shared by Genetic and Idiopathic Parkinson’s Disease Patient Fibroblasts
- (2012) Daniele Cartelli et al. PLoS One
- α-Synuclein Levels in Blood Plasma from LRRK2 Mutation Carriers
- (2012) Ana Gorostidi et al. PLoS One
- Brain Penetrant LRRK2 Inhibitor
- (2012) Hwan Geun Choi et al. ACS Medicinal Chemistry Letters
- Chemoproteomics-Based Design of Potent LRRK2-Selective Lead Compounds That Attenuate Parkinson’s Disease-Related Toxicity in Human Neurons
- (2011) Nigel Ramsden et al. ACS Chemical Biology
- Identification of chemicals to inhibit the kinase activity of leucine-rich repeat kinase 2 (LRRK2), a Parkinson’s disease-associated protein
- (2011) HyeJin Yun et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Transcriptional and Nontranscriptional Functions of E2F1 in Response to DNA Damage
- (2011) A. K. Biswas et al. CANCER RESEARCH
- LRRK2 Mutant iPSC-Derived DA Neurons Demonstrate Increased Susceptibility to Oxidative Stress
- (2011) Ha Nam Nguyen et al. Cell Stem Cell
- LRRK2 Parkinson disease mutations enhance its microtubule association
- (2011) Lauren R. Kett et al. HUMAN MOLECULAR GENETICS
- Roles of the Drosophila LRRK2 homolog in Rab7-dependent lysosomal positioning
- (2011) M. W. Dodson et al. HUMAN MOLECULAR GENETICS
- Inhibitors of LRRK2 kinase attenuate neurodegeneration and Parkinson-like phenotypes in Caenorhabditis elegans and Drosophila Parkinson's disease models
- (2011) Zhaohui Liu et al. HUMAN MOLECULAR GENETICS
- Mutations inLRRK2increase phosphorylation of peroxiredoxin 3 exacerbating oxidative stress-induced neuronal death
- (2011) Dario C. Angeles et al. HUMAN MUTATION
- Microtubule-associated Protein 1B (MAP1B) Is Required for Dendritic Spine Development and Synaptic Maturation
- (2011) Elena Tortosa et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Rare and common LRRK2 exonic variants in Parkinson's disease
- (2011) Eng-King Tan LANCET NEUROLOGY
- Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case–control study
- (2011) Owen A Ross et al. LANCET NEUROLOGY
- Distinct Autophagosomal-Lysosomal Fusion Mechanism Revealed by Thapsigargin-Induced Autophagy Arrest
- (2011) Ian G. Ganley et al. MOLECULAR CELL
- Characterization of a selective inhibitor of the Parkinson's disease kinase LRRK2
- (2011) Xianming Deng et al. Nature Chemical Biology
- Cerebrospinal fluid amyloid and tau in LRRK2 mutation carriers
- (2011) J. O. Aasly et al. NEUROLOGY
- Mouse models for LRRK2 Parkinson's disease
- (2011) Qing Xu et al. PARKINSONISM & RELATED DISORDERS
- Genetic variants in Sporadic Parkinson's Disease: East vs West
- (2011) Tasneem Peeraully et al. PARKINSONISM & RELATED DISORDERS
- α-Synuclein: Membrane Interactions and Toxicity in Parkinson's Disease
- (2010) Pavan K. Auluck et al. Annual Review of Cell and Developmental Biology
- LRRK2 and Parkinson Disease
- (2010) Justus C. Dächsel et al. ARCHIVES OF NEUROLOGY
- Inhibition of LRRK2 kinase activity leads to dephosphorylation of Ser910/Ser935, disruption of 14-3-3 binding and altered cytoplasmic localization
- (2010) Nicolas Dzamko et al. BIOCHEMICAL JOURNAL
- 14-3-3 binding to LRRK2 is disrupted by multiple Parkinson's disease-associated mutations and regulates cytoplasmic localization
- (2010) R. Jeremy Nichols et al. BIOCHEMICAL JOURNAL
- Development of Parkinson’s disease biomarkers
- (2010) Kumar M Prakash et al. Expert Review of Neurotherapeutics
- Activation of FoxO by LRRK2 induces expression of proapoptotic proteins and alters survival of postmitotic dopaminergic neuron in Drosophila
- (2010) Tomoko Kanao et al. HUMAN MOLECULAR GENETICS
- Insight into the mode of action of the LRRK2 Y1699C pathogenic mutant
- (2010) Veronique Daniëls et al. JOURNAL OF NEUROCHEMISTRY
- LRRK2 Kinase Regulates Synaptic Morphology through Distinct Substrates at the Presynaptic and Postsynaptic Compartments of the Drosophila Neuromuscular Junction
- (2010) S. Lee et al. JOURNAL OF NEUROSCIENCE
- Novel pathogenic LRRK2 p.Asn1437His substitution in familial Parkinson's disease
- (2010) Jan O. Aasly et al. MOVEMENT DISORDERS
- Pathogenic LRRK2 negatively regulates microRNA-mediated translational repression
- (2010) Stephan Gehrke et al. NATURE
- Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson's disease
- (2010) Byoung Dae Lee et al. NATURE MEDICINE
- Leucine-Rich Repeat Kinase 2 Gene-Associated Disease: Redefining Genotype-Phenotype Correlation
- (2010) Christian Wider et al. Neurodegenerative Diseases
- The Parkinson's Disease Associated LRRK2 Exhibits Weaker In Vitro Phosphorylation of 4E-BP Compared to Autophosphorylation
- (2010) Azad Kumar et al. PLoS One
- Loss of leucine-rich repeat kinase 2 causes impairment of protein degradation pathways, accumulation of -synuclein, and apoptotic cell death in aged mice
- (2010) Y. Tong et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- LRRK2 enhances oxidative stress-induced neurotoxicity via its kinase activity
- (2009) Hye Young Heo et al. EXPERIMENTAL CELL RESEARCH
- LRRK2 in Parkinson’s disease: genetic and clinical studies from patients
- (2009) Udhaya Kumari et al. FEBS Journal
- Leucine-rich repeat kinase 2 phosphorylates brain tubulin-beta isoforms and modulates microtubule stability - a point of convergence in Parkinsonian neurodegeneration?
- (2009) Frank Gillardon JOURNAL OF NEUROCHEMISTRY
- Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease
- (2009) Wataru Satake et al. NATURE GENETICS
- Interaction of elongation factor 1-alpha with leucine-rich repeat kinase 2 impairs kinase activity and microtubule bundling in vitro
- (2009) F. Gillardon NEUROSCIENCE
- Phosphorylation of 4E-BP by LRRK2 affects the maintenance of dopaminergic neurons in Drosophila
- (2008) Yuzuru Imai et al. EMBO JOURNAL
- LRRK2 regulates synaptic vesicle endocytosis
- (2008) Narae Shin et al. EXPERIMENTAL CELL RESEARCH
- Rab5 modulates aggregation and toxicity of mutant huntingtin through macroautophagy in cell and fly models of Huntington disease
- (2008) B. Ravikumar et al. JOURNAL OF CELL SCIENCE
- Role of autophagy in G2019S-LRRK2-associated neurite shortening in differentiated SH-SY5Y cells
- (2008) Edward D. Plowey et al. JOURNAL OF NEUROCHEMISTRY
- Parkinson's disease: clinical features and diagnosis
- (2008) J Jankovic JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- The Roc domain of leucine-rich repeat kinase 2 is sufficient for interaction with microtubules
- (2008) Payal N. Gandhi et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Molecular biology changes associated with LRRK2 mutations in Parkinson's disease
- (2008) Yi Wei Lu et al. JOURNAL OF NEUROSCIENCE RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More